Literature DB >> 2029761

Increased urinary nitrosamine excretion in paraplegic patients.

A R Tricker1, D J Stickler, J C Chawla, R Preussmann.   

Abstract

An increased risk of bladder cancer is a recognized complication in spine-injured patients undergoing long-term urethral catheterization to preserve renal function. Aerobic cultures from 28 of 30 paraplegic patients showed complex bacterial flora containing nitrate-reducing organisms (Escherichia coli, Proteus and Klebsiella spp.). Urine samples from 29 paraplegic patients were also found to contain volatile nitrosamines. Mean N-nitrosamine excretion levels were 0.65 +/- 0.69 micrograms/day N-nitrosodimethylamine, 0.25 +/- 0.44 micrograms/day N-nitrosopiperidine and 0.39 +/- 0.50 micrograms/day N-nitrosopyrrolidine. A mean urinary nitrite excretion of 10.4 +/- 13.2 mg/day was found in 24 out of 30 paraplegic patients. In the sterile urine of control volunteers (medical staff attending the paraplegic patients and in-patients from other wards of the hospital), no urinary excretion of volatile N-nitrosamines and nitrite was found. The results clearly demonstrate a bacterially mediated in vivo formation of N-nitroso compounds in the urinary tracts of paraplegic patients which may be an important etiological risk factor for bladder cancer in this patient group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029761     DOI: 10.1093/carcin/12.5.943

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

Review 2.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

3.  Mass spectrometric analysis of a cyclic 7,8-butanoguanine adduct of N-nitrosopyrrolidine: comparison to other N-nitrosopyrrolidine adducts in rat hepatic DNA.

Authors:  Ana Paula M Loureiro; Wenbing Zhang; Fekadu Kassie; Siyi Zhang; Peter W Villalta; Mingyao Wang; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

4.  Identification of adducts formed in the reaction of alpha-acetoxy-N-nitrosopyrrolidine with deoxyribonucleosides and DNA.

Authors:  Mingyao Wang; Yanbin Lao; Guang Cheng; Yongli Shi; Peter W Villalta; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2007-03-30       Impact factor: 3.739

5.  Nitrate contamination of drinking water: relationship with HPRT variant frequency in lymphocyte DNA and urinary excretion of N-nitrosamines.

Authors:  J M van Maanen; I J Welle; G Hageman; J W Dallinga; P L Mertens; J C Kleinjans
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

Review 6.  Molecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer.

Authors:  Salah A Sheweita; Awad S Alsamghan
Journal:  Mediators Inflamm       Date:  2020-07-08       Impact factor: 4.711

7.  Volatile N-nitrosamine formation after intake of nitrate at the ADI level in combination with an amine-rich diet.

Authors:  I T Vermeer; D M Pachen; J W Dallinga; J C Kleinjans; J M van Maanen
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

Review 8.  Urinary markers for exposures to alkylating or nitrosating agents.

Authors:  J S Wishnok; S R Tannenbaum; W G Stillwell; J A Glogowski; C D Leaf
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

9.  Paraplegia and squamous cell carcinoma of the bladder in young women: findings from a case-control study.

Authors:  P J Dolin; S C Darby; V Beral
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.